Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devan V Mehrotra

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Pharmaceutical Statistics|June 21, 2017
Missing data in clinical trials: control-based mean imputation and sensitivity analysisDevan V Mehrotra, Fang Liu, Thomas Permutt
Statistics in Medicine|March 23, 2012
An efficient alternative to the stratified Cox model analysisDevan V Mehrotra, Shu-Chih Su, Xiaoming Li
Statistics in Medicine|June 12, 2018
Incorporating baseline measurements into the analysis of crossover trials with time-to-event endpointsRengyi Xu, Devan V Mehrotra, Pamela A Shaw
Pharmaceutical Statistics|February 2, 2019
Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample sizeRengyi Xu, Devan V Mehrotra, Pamela A Shaw
Biometrics|September 21, 2006
A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trialDevan V Mehrotra, Xiaoming Li, Peter B Gilbert
Clinical Trials (London, England)|August 9, 2024
Analysis of composite time-to-event endpoints in cardiovascular outcome trialsRachel Marceau West, Gregory Golm, Devan V Mehrotra
Bioinformatics (Oxford, England)|February 27, 2020
Composite Kernel Association Test (CKAT) for SNP-set joint assessment of genotype and genotype-by-treatment interaction in Pharmacogenetics studiesHong Zhang, Ni Zhao, Devan V Mehrotra, et al.
Pharmaceutical Statistics|April 5, 2017
Enabling robust assessment of QTc prolongation in early phase clinical trialsDevan V Mehrotra, Li Fan, Fang Liu, et al.
Biometrics|September 22, 2012
Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regressionDevan V Mehrotra, Xiaoming Li, Jiajun Liu, et al.
Nature Communications|September 8, 2022
Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methodsSong Zhai, Hong Zhang, Devan V Mehrotra, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Pharmaceutical Statistics|June 21, 2017
Missing data in clinical trials: control-based mean imputation and sensitivity analysisDevan V Mehrotra, Fang Liu, Thomas Permutt
Statistics in Medicine|March 23, 2012
An efficient alternative to the stratified Cox model analysisDevan V Mehrotra, Shu-Chih Su, Xiaoming Li
Statistics in Medicine|June 12, 2018
Incorporating baseline measurements into the analysis of crossover trials with time-to-event endpointsRengyi Xu, Devan V Mehrotra, Pamela A Shaw
Pharmaceutical Statistics|February 2, 2019
Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample sizeRengyi Xu, Devan V Mehrotra, Pamela A Shaw
Biometrics|September 21, 2006
A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trialDevan V Mehrotra, Xiaoming Li, Peter B Gilbert
Clinical Trials (London, England)|August 9, 2024
Analysis of composite time-to-event endpoints in cardiovascular outcome trialsRachel Marceau West, Gregory Golm, Devan V Mehrotra
Bioinformatics (Oxford, England)|February 27, 2020
Composite Kernel Association Test (CKAT) for SNP-set joint assessment of genotype and genotype-by-treatment interaction in Pharmacogenetics studiesHong Zhang, Ni Zhao, Devan V Mehrotra, et al.
Pharmaceutical Statistics|April 5, 2017
Enabling robust assessment of QTc prolongation in early phase clinical trialsDevan V Mehrotra, Li Fan, Fang Liu, et al.
Biometrics|September 22, 2012
Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regressionDevan V Mehrotra, Xiaoming Li, Jiajun Liu, et al.
Nature Communications|September 8, 2022
Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methodsSong Zhai, Hong Zhang, Devan V Mehrotra, et al.
Pageof 8